Science

Mar 26, 2025, 09:08

Myeloma Paper of the Day, March 26th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Lachnospiraceae-inactivated phosphatidyl choline from myeloma cells inhibits CD8 T cell fxn via Sb9 mRNA maturation and exosomal Sb9 production via LPA reduces GZMB expression by suppressing tumor TP53 UFMylation in T cells.”

“Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma”

Authors: Wei Yan, Xue Shi, Yun Zhao, Xiaoyu Liu, Xueming Jia, Le Gao, Jiahe Yuan, Aijun Liao, Hiroshi Yasui, Xiaobin Wang, Xiaotian Wang, Rui Zhang and Huihan Wang.

More posts featuring Robert Orlowski.

Aijun Liao cancer Hiroshi Yasui Huihan Wang Jiahe Yuan Le Gao multiple myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Rui Zhang Wei Yan Xiaobin Wang Xiaotian Wang Xiaoyu Liu Xue Shi Xueming Jia Yun Zhao

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial